1. Home
  2. CSTE vs NRSN Comparison

CSTE vs NRSN Comparison

Compare CSTE & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$1.10

Market Cap

27.7M

Sector

Industrials

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.76

Market Cap

28.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTE
NRSN
Founded
1987
2017
Country
Israel
Israel
Employees
N/A
15
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
28.4M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
CSTE
NRSN
Price
$1.10
$0.76
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
2.5M
151.3K
Earning Date
03-04-2026
04-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.43
N/A
Revenue Next Year
$2.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$0.68
52 Week High
$3.26
$2.60

Technical Indicators

Market Signals
Indicator
CSTE
NRSN
Relative Strength Index (RSI) 47.19 40.45
Support Level $0.86 $0.68
Resistance Level $2.00 $1.30
Average True Range (ATR) 0.18 0.07
MACD 0.04 -0.01
Stochastic Oscillator 60.27 15.83

Price Performance

Historical Comparison
CSTE
NRSN

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: